CNS & Neurological Disorders - Drug Targets
Title:Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part II
Volume: 16 Issue: 2
Author(s): Yu-Dong Zhang, Ti-Fei Yuan and Zheng-Chao Dong
Affiliation:
Export Options
About this article
Cite this article as:
Zhang Yu-Dong, Yuan Ti-Fei and Dong Zheng-Chao, Editorial: Brain Imaging and Automatic Analysis in Neurological and Psychiatric Diseases – Part II, CNS & Neurological Disorders - Drug Targets 2017; 16 (2) . https://dx.doi.org/10.2174/187152731602170215204507
DOI https://dx.doi.org/10.2174/187152731602170215204507 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Herpes Simplex Virus Vectors for Gene Delivery to a Variety of Different Cell Types
Current Gene Therapy Therapeutic Use of MicroRNAs in Cancer
Anti-Cancer Agents in Medicinal Chemistry C-Methionine PET/CT in Central Nervous System Tumours: A Review
Current Radiopharmaceuticals Withdrawal Notice: Role, Significance and Association of microRNA-10a/b in Physiology of Cancer
MicroRNA Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy
Current Medicinal Chemistry Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry The Current Status of Novel PET Radio-Pharmaceuticals in Radiotherapy Treatment Planning of Glioma
Current Pharmaceutical Biotechnology Lysophospholipids: Synthesis and Biological Aspects
Current Organic Chemistry Has Bevacizumab (Avastin) Given Extra Therapeutic Gain in Metastatic Colorectal Cancer and Malignant Brain Gliomas? Systematic Review Answering this Question
Recent Patents on Inflammation & Allergy Drug Discovery Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs Exploration of the Medicinal Peptide Space
Protein & Peptide Letters Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology ADAMTS9-AS2: A Functional Long Non-coding RNA in Tumorigenesis
Current Pharmaceutical Design MARK1 is a Novel Target for miR-125a-5p: Implications for Cell Migration in Cervical Tumor Cells
MicroRNA Exploring the Role of Nerve Growth Factor in Multiple Sclerosis: Implications in Myelin Repair
CNS & Neurological Disorders - Drug Targets Diverse Models for the Prediction of Dual mTOR and PI3Kα Inhibitory Activities of Substituted 4-morpholinopyrrolopyrimidines
Letters in Drug Design & Discovery Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
Current Genomics Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism Telomerase Inhibition in Cancer Therapeutics: Molecular-Based Approaches
Current Medicinal Chemistry MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews